Viewing Study NCT05054751


Ignite Creation Date: 2025-12-24 @ 11:48 PM
Ignite Modification Date: 2026-01-03 @ 11:20 AM
Study NCT ID: NCT05054751
Status: COMPLETED
Last Update Posted: 2024-10-10
First Post: 2021-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Sponsor: Genor Biopharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module